ArticleTranslational cancer research2025
Differences in esophageal adenocarcinoma survival and treatment modalities by III/IV stage subgroup: a SEER population-based study.
Cheng Gong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.